XML 46 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restatement (Tables)
3 Months Ended
Mar. 31, 2018
Restatement  
Schedule of Consolidated Financial Statements Previously Issued

Following is a summary of the restatement changes made to the consolidated financial statements previously issued as of and for the three months ended March 31, 2018:

 

    Originally
Reported
    Restatement     As Restated  
    2018     2018     2018  
Consolidated balance sheet:                        
Derivative liabilities   $ -     $ 846,319     $ 846,319  
Additional paid-in capital   $ 24,655,946     $ (2,614,795 )   $ 22,041,151  
Accumulated deficit   $ 14,701,902     $ (1,768,476 )   $ 12,933,426  
                         

Consolidated Statement of Operations and

Comprehensive Loss:

                       
General and administrative   $ 3,169,787     $ 24,226     $ 3,194,013  
Change in fair value of derivative liabilities   $ -     $ 1,035,159     $ 1,035,159  
Net loss   $ 1,915,971     $ (1,010,933 )   $ 905,038  
Total comprehensive loss   $ 1,911,108     $ (1,010,933 )   $ 900,175  
                         
Consolidated Statements of Cash Flows:                        
Net loss   $ 1,915,971     $ (1,010,933 )   $ 905,038  
Stock compensation   $ 496,688     $ 24,226     $ 520,914  
Change in fair value of derivative liabilities   $ -     $ 1,035,159     $ 1,035,159  

Schedule of Fair Value Assumption Used

In determining the fair value of the derivative liabilities, the Company used the Black-Scholes option pricing model at March 31, 2018:

 

    March 31, 2018  
Common stock issuable upon exercise of warrants     1,032,717  
Market value of common stock on measurement date   $ 4.06  
Exercise price   $ 7.70 to $7.0  
Risk free interest rate(1)     2.27 %
Expected life in years     1.76 years  
Expected volatility (2)     72.36 %
Expected dividend yields (3)     0 %

 

(1) The risk-free interest rate was determined by management using the applicable Treasury Bill as of the measurement date.

(2) The historical trading volatility was determined by calculating the volatility of the Company’s peers common stock.

(3) The Company does not expect to pay a dividend in the foreseeable future.

Schedule of Fair Value of Derivative Liabilities on a Recurring Basis

The following table shows the change in the Company’s derivative liabilities that were accounted for at fair value on a recurring basis as of March 31, 2018:

 

    Amount  
Balance, December 31, 2017   $ 1,857,252  
Initial valuation of derivative liabilities upon issuance of warrants     24,226  
Change in fair value of derivative liabilities     (1,035,159 )
         
Balance, March 31, 2018     846,319